blood glucose monitoring
blood glucose monitoringReuters

Japan-based Omron Healthcare, which manufactures health monitoring products, said on Friday that it would expand its footprints in the Indian market and target 30 percent increase in its revenue in 2016.

"We recognise the potential that India offers as a market and (the company) will witness a 30 per cent growth this year," Hisao Masuda Healthcare, managing director of Omron, was quoted as saying by the Press Trust of India.

The company is looking to expand its presence to 26 cities of India in 2016. Currently, Omron is present in 16 cities of the country.

The healthcare product firm said that to achieve a target of increased revenue this year, it is looking to penetrate deeper into the Indian market.

Omron plans to raise awareness regarding the importance of using health monitoring devices in India and also explore e-business by selling the healthcare devices online, according to an official statement.

The Japanese firm said that India is a huge potential market for healthcare monitoring devices, especially as there people are becoming more aware of health issues at basic levels, where the company plays a major role.

The company's existing healthcare products in India include blood pressure, blood glucose monitors, nebulisers and body composition monitors.

"Our vision is to contribute to the advancement of India's healthy life through business operations and we are working to be the number one healthcare company in India," Masuda said

Omron's announcement comes days after the company saw a change in the guard with healthcare expert Ranndy Kellog taking over as the president and chief executive officer of the company on April 1, 2016.

"This year we are ramping up our mission to confront the ongoing epidemic of heart attacks and strokes – we will do that by building upon Omron's heritage of accuracy with new products that provide deeper insights, encourage behavioral change and promote healthier lifestyle habits," Kellog said.